USA. The “Three-Day Rule” Needs To Be Extended to Allow Longer Treatment With Methadone or Buprenorphine
USA. The “Three-Day Rule” Needs To Be Extended to Allow Longer Treatment With Methadone or Buprenorphine
In 2017, Gail Groves Scott, MPH, manager of the Substance Use Disorders Institute at the University of the Sciences in Philadelphia, wrote a passionate piece in the Philadelphia Inquirerabout the importance of expanding existing Drug Enforcement Administration (DEA) rules to expand and relax hospital regulations. Ms. Scott sought to remove the “three-day rule,” which limits treatment with methadone or buprenorphine for an opioid use disorder (OUD) to three days. A related rule requires hospitals to say whether the opioid addiction diagnosis is primary or secondary to other diseases for which the patient is being treated at the hospital, Ms. Scott wrote. (AT Forum, 18.01.2019)
http://atforum.com/2019/01/three-day-rule-allow-longer-treatment/